Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001971 · ClinicalTrials.gov registry record
Evaluation of Patients With Liver Disease
A clinical trial of Hepatitis C and Hepatitis B, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Recruiting
- Registry status
- 8,050
- Enrollment target
- 1
- Study location
NCT00001971: Recruiting study of Hepatitis C and Hepatitis B, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00001971 is a study of Hepatitis C and Hepatitis B that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 8,050 participants, above the 1,814-participant average among 106 other Hepatitis C trials with a reported enrollment target (344% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001971, a study of Hepatitis C and Hepatitis B, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- RECRUITING
- Registry status
- 8,050 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver. Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked to provide blood and urine samples for laboratory testing and will undergo an ultrasound of the liver. Ultrasound examinations use sound waves to determine the size and texture of the liver. After the initial visit subjects will be requested to follow-up once a year at the outpatient department for a similar check-up. Additional tests may be requested throughout the study to provide information for other research studies and individual consent will be requested. These tests may include liver biopsies, skin biopsies, and / or specialized blood, plasma, and lymphocyte examinations. Subjects that qualify for medications presently being studied may be offered the opportunity to benefit from experimental therapy.
Primary Outcome
Predisposition and outcomes related to liver disease susceptibility, progression, and treatment response
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,050 participants |
| Start Date | 1992-05-27 |
What NCT00001971 shows while recruiting
NCT00001971 is an observational study that tracks outcomes without assigning an intervention. Its 8,050 participants enrollment target places it among the larger protocols in the corpus, above the 1,814-participant average among 106 other Hepatitis C trials with a reported enrollment target (344% higher).
The record links to 4 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT00001971 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001971 about?
NCT00001971 is a clinical study titled "Evaluation of Patients With Liver Disease". The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver. Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked...
What is the current status of trial NCT00001971?
This trial is currently recruiting. The enrollment target is 8,050 participants. The study started on 1992-05-27.
What conditions does trial NCT00001971 study?
This clinical trial studies the following conditions: Hepatitis C, Hepatitis B, Liver Disease, Hepatitis D.
Who is sponsoring clinical trial NCT00001971?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001971 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001971's enrollment target sits among peer trials
8,050 3rd of 106 higher than 104 of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
-
HCV Tappt Adherence Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05593484 · 8,060 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
- NCT06184945 · 8,100 participants · NA
Behavioral Economic & Staffing Strategies in the ICU
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI